Sign in
227: UTILITY OF RASBURICASE VS. INTRAVENOUS ALLOPURINOL FOR NONMALIGNANCY-ASSOCIATED ACUTE HYPERURICEMIA
Abstract   Peer reviewed

227: UTILITY OF RASBURICASE VS. INTRAVENOUS ALLOPURINOL FOR NONMALIGNANCY-ASSOCIATED ACUTE HYPERURICEMIA

Jeff Moss, May Wu, David Axelrod and David Kwiatkowski
Critical care medicine, Vol.46(1), pp.96-96
01/2018
DOI: 10.1097/01.ccm.0000528246.63057.35

View Online

Details

Metrics

5 Record Views